Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rainer Boehm | M | 63 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Drapczuk | M | 48 |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | 5 years |
| Robert G. Savage | M | 70 | 3 years | |
| Morgan Lam | M | 59 | 2 years | |
| Ezra Friedberg | M | 53 | 1 years | |
| Dale B. Chappell | M | 53 | 1 years | |
| Michael W. P. Hermus | M | - |
House Party, Inc.
 House Party, Inc. Internet Software/ServicesTechnology Services House Party, Inc. organizes house parties and events. It puts brands into the hands, homes and conversations of consumer brand advocates through its member-based community, proprietary digital platform, and in home events. The company was founded by Gene DeRose and Parker Reilly in 2005 and is headquartered in Irvington, NY. | 4 years |
| Tarek Sahmoud | M | 63 | - | |
| Tariq Arshad | M | 54 | 2 years | |
| Amanda Wohlleber | F | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | 5 years |
| Philip Frost | M | 84 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 3 years |
| Angelo de Caro | M | 81 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 1 years |
| Sharon S. Clarke | F | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | - |
| J. Lobell | M | 61 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 2 years |
| Antony Pfaffle | M | 60 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 2 years |
| Christopher Maher | M | - |
House Party, Inc.
House Party, Inc. Internet Software/ServicesTechnology Services House Party, Inc. organizes house parties and events. It puts brands into the hands, homes and conversations of consumer brand advocates through its member-based community, proprietary digital platform, and in home events. The company was founded by Gene DeRose and Parker Reilly in 2005 and is headquartered in Irvington, NY. | - |
| Neil Herskowitz | M | 67 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 2 years |
| Steven Kelly | M | 59 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 6 years |
| Adam Craig | M | 58 |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | 2 years |
| Michael Dowd | M | - |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- J. Gregory Jester
- Personal Network
